SCHEMBL25351671

SCHEMBL25351671

CN(C)CCC(=O)Nc1cccc(-c2cn(Cc3ccc(-c4nnc(C(F)F)o4)cn3)nn2)c1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 13/20 0.47
▸ HDAC3 O15379 4/20 0.45
▸ HDAC1 Q13547 4/20 0.45
▸ HDAC2 Q92769 3/20 0.45
▸ HDAC10 Q969S8 3/20 0.45
▸ HDAC8 Q9BY41 3/20 0.45
▸ KDR P35968 2/20 0.40
▸ TEK Q02763 1/20 0.40
▸ AKT1 P31749 1/20 0.39
▸ UCHL5 Q9Y5K5 1/20 0.39
▸ TERT O14746 1/20 0.39
▸ USP2 O75604 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25350771 0.92 HDAC6 (0.48) HDAC6HDAC3HDAC1HDAC2HDAC10
SCHEMBL25216547 0.88 HDAC6 (0.51) HDAC6HDAC3HDAC1HDAC2HDAC10
SCHEMBL30424695 0.88 HDAC6 (0.51) HDAC6HDAC3HDAC1HDAC2HDAC10
SCHEMBL25351958 0.88 HDAC6 (0.52) HDAC6HDAC3HDAC1HDAC2HDAC10
SCHEMBL25352186 0.87 HDAC1 (0.46) HDAC6HDAC3HDAC1HDAC2HDAC10
SCHEMBL25350716 0.87 HDAC6 (0.47) HDAC6HDAC3HDAC1HDAC2HDAC10
SCHEMBL25350996 0.86 HDAC6 (0.49) HDAC6HDAC3HDAC1HDAC2HDAC10
SCHEMBL30410398 0.86 HDAC6 (0.49) HDAC6HDAC3HDAC1HDAC2HDAC10
SCHEMBL24216698 0.85 HDAC6 (0.49) HDAC6HDAC3HDAC1HDAC2HDAC10
SCHEMBL24216211 0.85 HDAC6 (0.49) HDAC6HDAC3HDAC1HDAC2HDAC10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-17 — — US disclosed
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-17 — — US disclosed
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME HDAC6, HDAC1, HDAC3 HDAC6 1/4885HDAC3 3/4885HDAC1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback